Optimal management of adults with ALL

British Journal of Haematology

Volumn 144, Issue 4, 2009, Pages 468-483

  Rowe, Jacob M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Acute lymphoblastic leukaemia; Adults; Minimal residual disease; Postremission therapy; Relapse

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IMATINIB; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CYTOGENETICS; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; PH MEASUREMENT; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REMISSION; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58649087583     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07513.x     Document Type: Review

References (102)

1. Annino, L., Vegna, M.L., Camera, A., Specchia, G., Visani, G., Fioritoni, G., Ferrara, F., Peta, A., Ciolli, S., Deplano, W., Fabbiano, F., Sica, S., Di Raimondo, F., Cascavilla, N., Tabilio, A., Leoni, P., Invernizzi, R., Baccarani, M., Rotoli, B., Amadori, S. Mandelli, F. (2002) Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood, 99, 863 871.
2. Avramis, V.I. Panosyan, E.H. (2005) Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clinical Pharmacokinetics, 44, 367 393.
3. Avramis, V.I., Sencer, S., Periclou, A.P., Sather, H., Bostrom, B.C., Cohen, L.J., Ettinger, A.G., Ettinger, L.J., Franklin, J., Gaynon, P.S., Hilden, J.M., Lange, B., Majlessipour, F., Mathew, P., Needle, M., Neglia, J., Reaman, G., Holcenberg, J.S. Stork, L. (2002) A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood, 99, 1986 1994.
4. Baak, U., Gokbuget, N., Orawa, H., Schwartz, S., Hoelzer, D., Thiel, E. Burmeister, T. (2008) Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group. Leukemia, 22, 1154 1160.
5. Bachanova, V. Weisdorf, D. (2008) Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review. Bone Marrow Transplantation, 41, 455 464.
6. Baldus, C.D., Burmeister, T., Martus, P., Schwartz, S., Gokbuget, N., Bloomfield, C.D., Hoelzer, D., Thiel, E. Hofmann, W.K. (2006) High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. Journal of Clinical Oncology, 24, 4714 4720.
7. Baldus, C.D., Martus, P., Burmeister, T., Schwartz, S., Gokbuget, N., Bloomfield, C.D., Hoelzer, D., Thiel, E. Hofmann, W.K. (2007) Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. Journal of Clinical Oncology, 25, 3739 3745.
8. Bassan, R., Pogliani, E., Casula, P., Rossi, G., Fabris, P., Morandi, S., Lambertenghi-Deliliers, G., Vespignani, M., Lerede, T., Rambaldi, A., Borleri, G., Spedini, P., Cortelezzi, A., Izzi, T., Coser, P., Broccia, G., Corneo, G. Barbui, T. (2001) Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups. The Hematology Journal, 2, 117 126.
9. Bleyer, A. (2005) The adolescent and young adult gap in cancer care and outcome. Current Problems in Pediatric and Adolescent Health Care, 35, 182 217.
10. Boissel, N., Auclerc, M.F., Lheritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.M., Gabert, J., Fegueux, N., Piguet, C., Huguet-Rigal, F., Berthou, C., Boiron, J.M., Pautas, C., Michel, G., Fiere, D., Leverger, G., Dombret, H. Baruchel, A. (2003) Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. Journal of Clinical Oncology, 21, 774 780.
11. de Bont, J.M., Holt, B., Dekker, A.W., van der Does-van den Berg, A., Sonneveld, P. Pieters, R. (2004) Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia, 18, 2032 2035.
12. Borowitz, M.J., Devidas, M., Hunger, S.P., Bowman, W.P., Carroll, A.J., Carroll, W.L., Linda, S., Martin, P.L., Pullen, D.J., Viswanatha, D., Willman, C.L., Winick, N. Camitta, B.M. (2008) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood, 111, 5477 5485.
13. Bruggemann, M., Raff, T., Flohr, T., Gokbuget, N., Nakao, M., Droese, J., Luschen, S., Pott, C., Ritgen, M., Scheuring, U., Horst, H.A., Thiel, E., Hoelzer, D., Bartram, C.R. Kneba, M. (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood, 107, 1116 1123.
14. Carnahan, J., Stein, R., Qu, Z., Hess, K., Cesano, A., Hansen, H.J. Goldenberg, D.M. (2007) Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Molecular Immunology, 44, 1331 1341.
15. Cortes, J., O'Brien, S.M., Pierce, S., Keating, M.J., Freireich, E.J. Kantarjian, H.M. (1995) The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood, 86, 2091 2097.
16. Coustan-Smith, E., Sancho, J., Behm, F.G., Hancock, M.L., Razzouk, B.I., Ribeiro, R.C., Rivera, G.K., Rubnitz, J.E., Sandlund, J.T., Pui, C.H. Campana, D. (2002) Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood, 100, 52 58.
17. DeAngelo, D.J., Yu, D., Johnson, J.L., Coutre, S.E., Stone, R.M., Stopeck, A.T., Gockerman, J.P., Mitchell, B.S., Appelbaum, F.R. Larson, R.A. (2007) Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood, 109, 5136 5142.
18. Dhedin, N., Dombret, H., Thomas, X., Lheritier, V., Boiron, J.M., Rigal-Huguet, F., Vey, N., Kuentz, M., Reman, O., Witz, F., Delannoy, A., Kovacsovics, T., Bradstock, K., Charrin, C., Boucheix, C., Gabert, J., Blaise, D., Fiere, D. Vernant, J.P. (2006) Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia, 20, 336 344.
19. Dombret, H., Gabert, J., Boiron, J.M., Rigal-Huguet, F., Blaise, D., Thomas, X., Delannoy, A., Buzyn, A., Bilhou-Nabera, C., Cayuela, J.M., Fenaux, P., Bourhis, J.H., Fegueux, N., Charrin, C., Boucheix, C., Lheritier, V., Esperou, H., MacIntyre, E., Vernant, J.P. Fiere, D. (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood, 100, 2357 2366.
20. Doney, K., Hagglund, H., Leisenring, W., Chauncey, T., Appelbaum, F.R. Storb, R. (2003) Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation, 9, 472 481.
21. Douer, D., Yampolsky, H., Cohen, L.J., Watkins, K., Levine, A.M., Periclou, A.P. Avramis, V.I. (2007) Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. Blood, 109, 2744 2750.
22. Fielding, A.K., Richards, S.M., Lazarus, H.M., Litzow, M.R., Luger, S.M., Marks, D.I., McMillan, A.K., Rowe, J.M., Tallman, M.S. Goldstone, A.H. (2007) Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study. Blood (ASH Annual Meeting Abstracts), 110, 8.
23. Fiere, D., Lepage, E., Sebban, C., Boucheix, C., Gisselbrecht, C., Vernant, J.P., Varet, B., Broustet, A., Cahn, J.Y., Rigal-Huguet, F., Witz, F., Michaux, J-L., Michallet, M. Reiffers, J. (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 11, 1990 2001.
24. Frankfurt, O. Tallman, M.S. (2007) Growth factors in leukemia. Journal of the National Comprehensive Cancer Network, 5, 203 215.
25. Gökbuget, N. Hoelzer, D. (2006) Treatment of adult acute lymphoblastic leukemia. Hematology. American Society of Hematology Educational Program, 2006, 133 141.
26. Gokbuget, N., Arnold, R., Buechner, T., Ganser, A., Ludwig, W-D., Maschmeyer, G., Rieder, H., Thiel, E., Messerer, D. Hoelzer, D. (2001) Intensification of induction and consolidation improves only subgroups of adult ALL: analysis of 1200 patients in GMALL study 05/93. Blood, 98, 802a.
27. Goldstone, A.H., Chopra, R., Buck, G., Richards, S.M., Franklin, I.M., Lazarus, H.M., Wiernik, P.H., Tallman, M.S., Prentice, H.G., Durrant, J. Rowe, J.M. (2003) The outcome of 267 Philadelphia-positive adults in the International UKALL XII/ ECOG E2993 study. Final analysis and the role of allogeneic transplant in those under 50 years. Blood, 104, 268a.
28. Goldstone, A.H., Richards, S.M., Lazarus, H.M., Tallman, M.S., Buck, G., Fielding, A.K., Burnett, A.K., Chopra, R., Wiernik, P.H., Foroni, L., Paietta, E., Litzow, M.R., Marks, D.I., Durrant, J., McMillan, A., Franklin, I.M., Luger, S., Ciobanu, N. Rowe, J.M. (2008a) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood, 111, 1827 1833.
29. Goldstone, A.H., Richards, S.M., Fielding, A.K. Rowe, J.M. (2008b) Chemotherapy or allografting for young adults with high-risk ALL. Blood, 111, 5755.
30. Gutierrez-Aguirre, C.H., Gomez-Almaguer, D., Cantu-Rodriguez, O.G., Gonzalez-Llano, O., Jaime-Perez, J.C., Herena-Perez, S., Manzano, C.A., Estrada-Gomez, R., Gonzalez-Carrillo, M.L. Ruiz-Arguelles, G.J. (2007) Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study. Bone Marrow Transplantation, 40, 535 539.
31. Hallbook, H., Simonsson, B., Ahlgren, T., Bjorkholm, M., Carneskog, J., Grimfors, G., Hast, R., Karlsson, K., Kimby, E., Lerner, R., Linder, O., Linderholm, M., Lofvenberg, E., Malm, C., Nilsson, P.G., Paul, C., Stenke, L., Stockelberg, D., Tidefelt, U., Turesson, I., Uden-Blome, A.M., Vilen, L., Wahlin, A., Winquist, I. Smedmyr, B. (2002) High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. British Journal of Haematology, 118, 748 754.
32. Hallbook, H., Gustafsson, G., Smedmyr, B., Soderhall, S. Heyman, M. (2006) Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer, 107, 1551 1561.
33. Hamaki, T., Kami, M., Kanda, Y., Yuji, K., Inamoto, Y., Kishi, Y., Nakai, K., Nakayama, I., Murashige, N., Abe, Y., Ueda, Y., Hino, M., Inoue, T., Ago, H., Hidaka, M., Hayashi, T., Yamane, T., Uoshima, N., Miyakoshi, S. Taniguchi, S. (2005) Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients. Bone Marrow Transplantation, 35, 549 556.
34. Hoelzer, D. Gökbuget, N. (2005) Treatment of elderly patients with acute lymphoblastic leukemia. ASCO Education Book, 533 539. ASCO, Alexandria, VA.
35. Hoelzer, D., Hiddemann, W., Baumann, A., Döhner, H., Dührsen, U., Fietkau, R., Hansmann, M-L., Hüttmann, A., Irmer, S., Kaun, S., Kneba, M., Reichle, A., Schmid, M., Schmidt-Wolf, I., Thiel, E., Walewski, J. Gökbuget, N. (2007) High Survival Rate in Adult Burkitt's Lymphoma/Leukemia and Diffuse Large B-Cell Lymphoma with Mediastinal Involvement. Blood, 110, 518a.
36. Holowiecki, J., Krawczyk-Kulis, M., Giebel, S., Jagoda, K., Stella-Holowiecka, B., Piatkowska-Jakubas, B., Paluszewska, M., Seferynska, I., Lewandowski, K., Kielbinski, M., Czyz, A., Balana-Nowak, A., Krol, M., Skotnicki, A.B., Jedrzejczak, W.W., Warzocha, K., Lange, A. Hellmann, A. (2008) Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study. British Journal of Haematology, 142, 227 237.
37. Hunault, M., Harousseau, J.L., Delain, M., Truchan-Graczyk, M., Cahn, J.Y., Witz, F., Lamy, T., Pignon, B., Jouet, J.P., Garidi, R., Caillot, D., Berthou, C., Guyotat, D., Sadoun, A., Sotto, J.J., Lioure, B., Casassus, P., Solal-Celigny, P., Stalnikiewicz, L., Audhuy, B., Blanchet, O., Baranger, L., Bene, M.C. Ifrah, N. (2004) Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood, 104, 3028 3037.
38. Jabbour, E., O'Brien, S., Kantarjian, H., Garcia-Manero, G., Ferrajoli, A., Ravandi, F., Cabanillas, M. Thomas, D.A. (2007a) Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood, 109, 3214 3218.
39. Jabbour, E., Cortes, J., Giles, F., O'Brien, S. Kantarijan, H. (2007b) Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond. IDrugs, 10, 468 479.
40. Jacobs, A.D. Gale, R.P. (1984) Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. New England Journal of Medicine, 311, 1219 1231.
41. Jandula, B.M., Nomdedeu, J., Marin, P. Vivancos, P. (2001) Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia. Bone Marrow Transplantation, 27, 225 227.
42. Jeha, S., Gaynon, P.S., Razzouk, B.I., Franklin, J., Kadota, R., Shen, V., Luchtman-Jones, L., Rytting, M., Bomgaars, L.R., Rheingold, S., Ritchey, K., Albano, E., Arceci, R.J., Goldman, S., Griffin, T., Altman, A., Gordon, B., Steinherz, L., Weitman, S. Steinherz, P. (2006) Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Journal of Clinical Oncology, 24, 1917 1923.
43. Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C.S., Keating, M.J., Murphy, S. Freireich, E.J. (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology, 18, 547 561.
44. Kantarjian, H., Thomas, D., O'Brien, S., Cortes, J., Giles, F., Jeha, S., Bueso-Ramos, C.E., Pierce, S., Shan, J., Koller, C., Beran, M., Keating, M. Freireich, E.J. (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer, 101, 2788 2801.
45. Kiehl, M.G., Kraut, L., Schwerdtfeger, R., Hertenstein, B., Remberger, M., Kroeger, N., Stelljes, M., Bornhaeuser, M., Martin, H., Scheid, C., Ganser, A., Zander, A.R., Kienast, J., Ehninger, G., Hoelzer, D., Diehl, V., Fauser, A.A. Ringden, O. (2004) Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. Journal of Clinical Oncology, 22, 2816 2825.
46. Labar, B., Suciu, S., Zittoun, R., Muus, P., Marie, J.P., Fillet, G., Peetermans, M., Stryckmans, P., Willemze, R., Feremans, W., Jaksic, B., Bourhis, J.H., Burghouts, J.P. de Witte, T. (2004) Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients
47. de Labarthe, A., Rousselot, P., Huguet-Rigal, F., Delabesse, E., Witz, F., Maury, S., Rea, D., Cayuela, J.M., Vekemans, M.C., Reman, O., Buzyn, A., Pigneux, A., Escoffre, M., Chalandon, Y., MacIntyre, E., Lheritier, V., Vernant, J.P., Thomas, X., Ifrah, N. Dombret, H. (2007) Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood, 109, 1408 1413.
48. Laport, G.G., Alvarnas, J.C., Palmer, J.M., Snyder, D.S., Slovak, M.L., Cherry, A.M., Wong, R.M., Negrin, R.S., Blume, K.G. Forman, S.J. (2008) Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. Blood, 112, 903 909.
49. Larson, R.A. (2006) Management of acute lymphoblastic leukemia in older patients. Seminars in Hematology, 43, 126 133.
50. Larson, R.A., Dodge, R.K., Linker, C.A., Stone, R.M., Powell, B.L., Lee, E.J., Schulman, P., Davey, F.R., Frankel, S.R., Bloomfield, C.D., George, S.L. Schiffer, C.A. (1998) A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood, 92, 1556 1564.
51. Lazarus, H.M., Richards, S.M., Chopra, R., Litzow, M.R., Burnett, A.K., Wiernik, P.H., Franklin, I.M., Tallman, M.S., Cook, L., Buck, G., Durrant, I.J., Rowe, J.M. Goldstone, A.H. (2006) Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood, 108, 465 472.
52. Lee, K.H., Lee, J.H., Choi, S.J., Seol, M., Lee, Y.S., Kim, W.K., Lee, J.S., Seo, E.J., Jang, S., Park, C.J. Chi, H.S. (2005a) Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia, 19, 1509 1516.
53. Lee, S., Kim, Y.J., Min, C.K., Kim, H.J., Eom, K.S., Kim, D.W., Lee, J.W., Min, W.S. Kim, C.C. (2005b) The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood, 105, 3449 3457.
54. Leonard, J.P., Coleman, M., Ketas, J.C., Chadburn, A., Ely, S., Furman, R.R., Wegener, W.A., Hansen, H.J., Ziccardi, H., Eschenberg, M., Gayko, U., Cesano, A. Goldenberg, D.M. (2003) Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. Journal of Clinical Oncology, 21, 3051 3059.
55. Leonard, J.P., Coleman, M., Ketas, J.C., Chadburn, A., Furman, R., Schuster, M.W., Feldman, E.J., Ashe, M., Schuster, S.J., Wegener, W.A., Hansen, H.J., Ziccardi, H., Eschenberg, M., Gayko, U., Fields, S.Z., Cesano, A. Goldenberg, D.M. (2004) Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. Clinical Cancer Research, 10, 5327 5334.
56. Leonard, J.P., Coleman, M., Ketas, J., Ashe, M., Fiore, J.M., Furman, R.R., Niesvizky, R., Shore, T., Chadburn, A., Horne, H., Kovacs, J., Ding, C.L., Wegener, W.A., Horak, I.D. Goldenberg, D.M. (2005) Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma. Journal of Clinical Oncology, 23, 5044 5051.
57. Linker, C., Damon, L., Ries, C. Navarro, W. (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 2464 2471.
58. Mancini, M., Cimino, G., Vegna, M.L., Vitale, A., Annino, A., Derme, V., Buffalino, S., Cuneo, A., Castoldi, G.L., Mecucci, C., Saglio, G., Pane, F., Carella, A.L., Fabbiano, F., Ferrara, F., Gallo, E., Palumbo, G.A., Kropp, M.G., Liso, V., Pizzolo, G., Ronco, F., Spadano, A., Tedeschi, A., Mandelli, F. Foa, R. (2001) An integrated molecular-cytogenetic classification is highly predictive of outcome in adult acute lymphoblastic leukemia (ALL): analysis of 395 cases enrolled in the GIMEMA 0496 trial. Blood, 98, 3492a.
59. Marks, D.I., Perez, W.S., He, W., Zhang, M.J., Bishop, M.R., Bolwell, B.J., Bredeson, C.N., Copelan, E.A., Gale, R.P., Gupta, V., Hale, G.A., Isola, L.M., Jakubowski, A.A., Keating, A., Klumpp, T.R., Lazarus, H.M., Liesveld, J.L., Maziarz, R.T., McCarthy, P.L., Sabloff, M., Schiller, G., Sierra, J., Tallman, M.S., Waller, E.K., Wiernik, P.H. Weisdorf, D.J. (2008) Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood, 112, 426 434.
60. Martino, R., Giralt, S., Caballero, M.D., Mackinnon, S., Corradini, P., Fernandez-Aviles, F., San Miguel, J. Sierra, J. (2003) Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica, 88, 555 560.
61. Mohty, M., Labopin, M., Tabrizzi, R., Theorin, N., Fauser, A.A., Rambaldi, A., Maertens, J., Slavin, S., Majolino, I., Nagler, A., Blaise, D. Rocha, V. (2008) Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Haematologica, 93, 303 306.
62. Moorman, A.V., Harrison, C.J., Buck, G.A., Richards, S.M., Secker-Walker, L.M., Martineau, M., Vance, G.H., Cherry, A.M., Higgins, R.R., Fielding, A.K., Foroni, L., Paietta, E., Tallman, M.S., Litzow, M.R., Wiernik, P.H., Rowe, J.M., Goldstone, A.H. Dewald, G.W. (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 109, 3189 3197.
63. Mortuza, F.Y., Papaioannou, M., Moreira, I.M., Coyle, L.A., Gameiro, P., Gandini, D., Prentice, H.G., Goldstone, A., Hoffbrand, A.V. Foroni, L. (2002) Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 1094 1104.
64. Nowak-Gottl, U., Ahlke, E., Fleischhack, G., Schwabe, D., Schobess, R., Schumann, C. Junker, R. (2003) Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood, 101, 2529 2533.
65. Ortega, J.A., Nesbit, Jr., M.E., Donaldson, M.H., Hittle, R.E., Weiner, J., Karon, M. Hammond, D. (1977) L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Research, 37, 535 540.
66. Ottmann, O.G., Wassmann, B., Pfeifer, H., Giagounidis, A., Stelljes, M., Duhrsen, U., Schmalzing, M., Wunderle, L., Binckebanck, A. Hoelzer, D. (2007) Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Cancer, 109, 2068 2076.
67. Palomero, T. Ferrando, A. (2008) Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clinical Cancer Research, 14, 5314 5317.
68. Petersdorf, S.H., Kopecky, K.J., Head, D.R., Boldt, D.H., Balcerzak, S.P., Wun, T., Roy, V., Veith, R.W. Appelbaum, F.R. (2001) Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study. Leukemia, 15, 208 216.
69. Pui, C.H. Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166 178.
70. Pui, C.H., Robison, L.L. Look, A.T. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 1030 1043.
71. Pullarkat, V., Slovak, M.L., Kopecky, K.J., Forman, S.J. Appelbaum, F.R. (2008) Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood, 111, 2563 2572.
72. Ramanujachar, R., Richards, S., Hann, I. Webb, D. (2006) Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatric Blood & Cancer, 47, 748 756.
73. Ribera, J.M., Oriol, A., Bethencourt, C., Parody, R., Hernandez-Rivas, J.M., Moreno, M.J., del Potro, E., Torm, M., Rivas, C., Besalduch, J., Sanz, M.A. Ortega, J.J. (2005) Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica, 90, 1346 1356.
74. Rowe, J.M. (2008) Graft versus Disease Effect following allogeneic transplantation for acute leukemia. Best Practice & Research. Clinical Haematology, 21, 485 502.
75. Rowe, J.M., Buck, G., Burnett, A.K., Chopra, R., Wiernik, P.H., Richards, S.M., Lazarus, H.M., Franklin, I.M., Litzow, M.R., Ciobanu, N., Prentice, H.G., Durrant, J., Tallman, M.S. Goldstone, A.H. (2005) Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106, 3760 3767.
76. Schiffer, C.A. (2003) Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both? Journal of Clinical Oncology, 21, 760 761.
77. Schroder, H., Kjeldahl, M., Boesen, A.M., Nielsen, O.J., Schmidt, K., Johnsen, H.E., Gregersen, H., Heyman, M. Gustafsson, G. (2006) Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark - secondary publication. Danish Medical Bulletin, 53, 76 79.
78. Sebban, C., Lepage, E., Vernant, J.P., Gluckman, E., Attal, M., Reiffers, J., Sutton, L., Racadot, E., Michallet, M., Maraninchi, D., Dreyfus, F Fiere, D. (1994) Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 12, 2580 2587.
79. Shah, N.P., Tran, C., Lee, F.Y., Chen, P., Norris, D. Sawyers, C.L. (2004) Overriding imatinib resistance with a novel ABL kinase inhibitor. Science, 305, 399 401.
80. Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J. Sallan, S.E. (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood, 97, 1211 1218.
81. Stein, A., O'Donnell, M., Snyder, D, Parker, P., Nademanee, A., Falk, P., Kogut, N., Rosenthal, J., Palmer, J., Tsail, N. Forman, S. (2007) Reduced-intensity stem cell transplantation for high-risk acute lymphoblastic leukemia. Biology Blood Marrow Transplantation, 13, 134a.
82. Stock, W., La, M., Sanford, B., Bloomfield, C.D., Vardiman, J.W., Gaynon, P., Larson, R.A. Nachman, J. (2008) What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of children's cancer group and cancer and leukemia group b studies. Blood, 112, 1646 1654.
83. Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, A., Fisher, L., Buckner, C.D., Anasetti, C., Appelbaum, F.R. Badger, C. (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 1720 1728.
84. Szczepanski, T. (2007) Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia, 21, 622 626.
85. Takeuchi, J., Kyo, T., Naito, K., Sao, H., Takahashi, M., Miyawaki, S., Kuriyama, K., Ohtake, S., Yagasaki, F., Murakami, H., Asou, N., Ino, T., Okamoto, T., Usui, N., Nishimura, M., Shinagawa, K., Fukushima, T., Taguchi, H., Morii, T., Mizuta, S., Akiyama, H., Nakamura, Y., Ohshima, T. Ohno, R. (2002) Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia, 16, 1259 1266.
86. Tavernier, E., Boiron, J.M., Huguet, F., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lheritier, V., Vernant, J.P., Dombret, H. Thomas, X. (2007) Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia, 21, 1907 1914.
87. Thiebaut, A., Vernant, J.P., Degos, L., Huguet, F.R., Reiffers, J., Sebban, C., Lepage, E., Thomas, X. Fiere, D. (2000) Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematology/Oncology Clinics of North America, 14, 1353 1366, X.
88. Thomas, X., Boiron, J.M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Vernant, J.P., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lheritier, V. Fiere, D. (2004a) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. Journal of Clinical Oncology, 22, 4075 4086.
89. Thomas, D.A., Faderl, S., Cortes, J., O'Brien, S., Giles, F.J., Kornblau, S.M., Garcia-Manero, G., Keating, M.J., Andreeff, M., Jeha, S., Beran, M., Verstovsek, S., Pierce, S., Letvak, L., Salvado, A., Champlin, R., Talpaz, M. Kantarjian, H. (2004b) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood, 103, 4396 4407.
90. Thomas, D.A., Faderl, S., O'Brien, S., Bueso-Ramos, C., Cortes, J., Garcia-Manero, G., Giles, F.J., Verstovsek, S., Wierda, W.G., Pierce, S.A., Shan, J., Brandt, M., Hagemeister, F.B., Keating, M.J., Cabanillas, F. Kantarjian, H. (2006a) Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer, 106, 1569 1580.
91. Thomas, D.A., Sarris, A.H., Cortes, J., Faderl, S., O'Brien, S., Giles, F.J., Garcia-Manero, G., Rodriguez, M.A., Cabanillas, F. Kantarjian, H. (2006b) Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia. Cancer, 106, 120 127.
92. Tibes, R., Keating, M.J., Ferrajoli, A., Wierda, W., Ravandi, F., Garcia-Manero, G., O'Brien, S., Cortes, J., Verstovsek, S., Browning, M.L. Faderl, S. (2006) Activity of alemtuzumab in patients with CD52-positive acute leukemia. Cancer, 106, 2645 2651.
93. Vignetti, M., Fazi, P., Cimino, G., Martinelli, G., Di Raimondo, F., Ferrara, F., Meloni, G., Ambrosetti, A., Quarta, G., Pagano, L., Rege-Cambrin, G., Elia, L., Bertieri, R., Annino, L., Foa, R., Baccarani, M. Mandelli, F. (2007) Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood, 109, 3676 3678.
94. de Vries, M.J., Veerman, A.J. Zwaan, C.M. (2004) Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma. British Journal of Haematology, 125, 414 415.
95. Vujovic, S., Henderson, S.R., Flanagan, A.M. Clements, M.O. (2007) Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cells. Cell Proliferation, 40, 185 195.
96. Wassmann, B., Pfeifer, H., Goekbuget, N., Beelen, D.W., Beck, J., Stelljes, M., Bornhauser, M., Reichle, A., Perz, J., Haas, R., Ganser, A., Schmid, M., Kanz, L., Lenz, G., Kaufmann, M., Binckebanck, A., Bruck, P., Reutzel, R., Gschaidmeier, H., Schwartz, S., Hoelzer, D. Ottmann, O.G. (2006) Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood, 108, 1469 1477.
97. Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D. Storb, R. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New England Journal of Medicine, 300, 1068 1073.
98. Wetzler, M., Sanford, B.L., Kurtzberg, J., DeOliveira, D., Frankel, S.R., Powell, B.L., Kolitz, J.E., Bloomfield, C.D. Larson, R.A. (2007) Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511. Blood, 109, 4164 4167.
99. Yanada, M., Matsuo, K., Suzuki, T. Naoe, T. (2006a) Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer, 106, 2657 2663.
100. Yanada, M., Takeuchi, J., Sugiura, I., Akiyama, H., Usui, N., Yagasaki,
101. Zhang, M.J., Hoelzer, D., Horowitz, M.M., Gale, R.P., Messerer, D., Klein, J.P., Loffler, H., Sobocinski, K.A., Thiel, E. Weisdorf, D.J. (1995) Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. Annals of Internal Medicine, 123, 428 431.
102. Zhou, J., Goldwasser, M.A., Li, A., Dahlberg, S.E., Neuberg, D., Wang, H., Dalton, V., McBride, K.D., Sallan, S.E., Silverman, L.B. Gribben, J.G. (2007) Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01. Blood, 110, 1607 1611.